Showing results (311-320 of 332) with videos related to
Sort By:
Pageof 34
Transplantation and Cellular Therapy|July 28, 2024
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMORebeca Bailén, Gloria Iacoboni, Javier Delgado, et al.Leukemia|June 3, 2021
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective surveyPer Ljungman, Rafael de la Camara, Malgorzata Mikulska, et al.Allergy, Asthma & Immunology Research|January 21, 2019
Multicenter Adherence Study of Asthma Medication for Children in KoreaChang Keun Kim, Zak Callaway, Jungi Choi, et al.Haematologica|June 30, 2022
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Gloria Iacoboni, Juan Luis Reguera, et al.Plos One|October 17, 2015
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell TransplantationVíctor Noriega, Carolina Martínez-Laperche, Elena Buces, et al.Bone Marrow Transplantation|May 27, 2025
Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMTJuan Montoro, Dirk-Jan Eikema, Brian Piepenbroek, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
The Potential of the Gut Microbiota and Butyrate to Enhance CAR-T Cell Therapy in Non-Hodgkin LymphomaRoberto Garcia-Vicente, Alba Rodríguez-García, Raquel Ancos-Pintado, et al.Journal of Hematology & Oncology|October 29, 2024
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatmentGloria Iacoboni, Víctor Navarro, Pierre Sesques, et al.Transplantation and Cellular Therapy|January 14, 2026
Haploidentical Donor vs. Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplant, a GETH-TC StudyMaría Laura Fox, Ariadna Pérez Martínez, Albert Esquirol, et al.Hemasphere|May 22, 2024
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapyGloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, et al.Pageof 34